Is the fixed-dose combination of telmisartan and hydrochlorothiazide a good approach to treat hypertension?
Blockade of the renin-angiotensin system with selective AT1 receptor antagonists is recognized as an effective mean to lower blood pressure in hypertensive patients. Among the class of AT1 receptor antagonists, telmisartan offers the advantage of a very long half-life. This enables blood pressure control over 24 hours using once-daily administration. The combination of telmisartan with hydrochlorothiazide is a logical step because numerous previous studies have demonstrated that sodium depletion enhances the antihypertensive efficacy of drugs interfering with the activity of the renin-angiotensin system (RAS). In accordance with past experience using similar compounds blocking the RAS, several controlled studies have now demonstrated that the fixed-dose combination oftelmisartan/hydrochlorothiazide is superior in lowering blood pressure than either telmisartan or hydrochlorothiazide alone. Of clinical interest also is the observation that the excellent clinical tolerance of the angiotensin II receptor antagonist is not affected by the association of the low-dose thiazide. Thus telmisartan/hydrochlorothiazide is an effective and well-tolerated antihypertensive combination. Finally, the development of fixed-dose combinations should improve drug adherence because of the one-pill-a-day regimen.
Maillard
Marc P
MP
Service of Nephrology, Department of Internal Medicine, Lausanne University Hospital, Switzerland. marc.maillard@chuv.ch
Burnier
Michel
M
D047228:Angiotensin II Type 1 Receptor Blockers / Q000494:pharmacology* / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000494:pharmacology* / Q000627:therapeutic use; D001562:Benzimidazoles / Q000494:pharmacology* / Q000627:therapeutic use; D001565:Benzoates / Q000494:pharmacology* / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006801:Humans; D006852:Hydrochlorothiazide / Q000494:pharmacology* / Q000627:therapeutic use; D006973:Hypertension / Q000188:drug therapy*; D016032:Randomized Controlled Trials as Topic; D012084:Renin-Angiotensin System / Q000187:drug effects; D000077333:Telmisartan
D047228:Angiotensin II Type 1 Receptor Blockers; D000959:Antihypertensive Agents; D001562:Benzimidazoles; D001565:Benzoates; D006852:Hydrochlorothiazide; D000077333:Telmisartan
J Renin Angiotensin Aldosterone Syst. 2001 Mar;2(1):31-6
11881063
Drug Saf. 2003;26(10):707-20
12862505
Diabetes Care. 2005 Mar;28(3):757-8
15735228
N Engl J Med. 2001 Sep 20;345(12):851-60
11565517
J Renin Angiotensin Aldosterone Syst. 2001 Jun;2(2):123-8
11881111
J Clin Hypertens (Greenwich). 2002 Jul-Aug;4(4 Suppl 1):20-5
12147925
Clin Ther. 1998 Jul-Aug;20(4):671-81
9737827
Int J Cardiol. 2004 Dec;97(3):383-8
15561322
J Int Med Res. 2001 Mar-Apr;29(2):131-9
11393346
Blood Press. 2002;11(5):302-9
12458653
J Hypertens. 2005 Nov;23(11):2055-61
16208149
J Cardiovasc Pharmacol. 2001 Nov;38(5):672-85
11602814
Diabetes Res Clin Pract. 2006 Feb;71(2):210-9
16112244
Nephrol Dial Transplant. 2003 Oct;18(10):1969-73
13679466
J Clin Endocrinol Metab. 2004 Mar;89(3):1140-5
15001599
Drugs. 2001;61(10):1501-29
11558835
N Engl J Med. 1994 Jun 30;330(26):1852-7
8196728
Lancet. 1998 Jun 13;351(9118):1755-62
9635947
Psychosom Med. 1999 May-Jun;61(3):311-8
10367611
N Engl J Med. 2004 Nov 4;351(19):1952-61
15516696
Am J Geriatr Cardiol. 2006 May-Jun;15(3):151-60
16687967
Am J Cardiovasc Drugs. 2005;5(3):171-83
15901205
Am Heart J. 2004 Jul;148(1):52-61
15215792
Kidney Int Suppl. 1988 Oct;26:S80-5
2904507
Drugs. 2003;63(19):2013-26; discussion 2027-8
12962518
Clin Cardiol. 2001 Jan;24(1):66-72
11195609
Hypertens Res. 2004 Jul;27(7):457-64
15302981
Acta Diabetol. 2005 Apr;42 Suppl 1:S9-16
15868121
J Clin Pharmacol. 2000 Dec;40(12 Pt 1):1312-22
11185629
N Engl J Med. 2001 Sep 20;345(12):870-8
11565519
Drug Saf. 2004;27(5):335-44
15061687
J Hypertens. 1994 Feb;12(2):119-28
8021462
J Pharmacol Exp Ther. 2002 Sep;302(3):1089-95
12183667
JAMA. 2002 Dec 18;288(23):2981-97
12479763
Cardiovasc Drugs Ther. 2003 Sep-Nov;17(5-6):397-414
15107595
J Med Chem. 1996 May 24;39(11):2197-206
8667363
N Engl J Med. 2001 Sep 20;345(12):861-9
11565518
Drugs. 1994 Jul;48(1):16-24
7525192
Theor Biol Med Model. 2006 Jan 10;3:1
16403216
Diabetes. 2005 Dec;54(12):3442-52
16306360
Expert Opin Pharmacother. 2004 Nov;5(11):2303-10
15500377
Mol Cell Biochem. 1996 Oct-Nov;163-164:217-21
8974060
Hypertension. 2003 Dec;42(6):1206-52
14656957
J Hum Hypertens. 2004 Jan;18(1):53-9
14688811
J Hypertens. 2003 Oct;21(10):1779-86
14508180
J Hypertens Suppl. 2003 Jul;21(6):S37-46
14513950
Expert Rev Cardiovasc Ther. 2005 May;3(3):375-86
15889965
Drugs. 2006;66(1):51-83
16398568
Hypertension. 2004 May;43(5):993-1002
15007034
Eur J Clin Pharmacol. 1977 Dec 2;12(4):297-303
590315
J Hypertens. 2004 Jun;22(6):1213-20
15167457
J Hum Hypertens. 2005 Aug;19(8):607-13
15920457
J Hypertens. 1995 Aug;13(8):891-9
8557967
J Int Med Res. 2002 Jul-Aug;30(4):366-79
12235918
Arzneimittelforschung. 1996 Aug;46(8):755-9
9125273
Br J Pharmacol. 1993 Sep;110(1):245-52
8220885
Hypertension. 1999 Apr;33(4):1043-8
10205245
Clin Pharmacol Ther. 1980 Mar;27(3):328-36
6987024
Arch Intern Med. 1996 Sep 23;156(17):1969-78
8823150
J Hum Hypertens. 2003 Aug;17(8):569-75
12874615
Am J Hypertens. 2003 May;16(5 Pt 1):421-5
12745206
J Med Chem. 1993 Dec 10;36(25):4040-51
8258826
Vasc Med. 2005 Jul;10 Suppl 1:S97-102
16444875
J Hum Hypertens. 2001 Nov;15(11):763-70
11687919
Prog Cardiovasc Dis. 2006 Jul-Aug;49(1):16-25
16867847
J Int Med Res. 2005 Nov-Dec;33(6):677-86
16372586
Expert Opin Pharmacother. 2002 May;3(5):529-40
11996632
Int J Clin Pract. 1999 Apr-May;53(3):175-8
10665127
J Cardiovasc Risk. 1998 Jun;5(3):161-6
10201552
Clin Ther. 2001 Dec;23(12):1999-2010
11813934
Am J Ther. 1999 May;6(3):161-6
10423659
J Hypertens. 1999 Feb;17(2):293-302
10067800
Am J Cardiovasc Drugs. 2001;1(4):263-79
14728026
J Pharmacol Exp Ther. 2001 Jul;298(1):62-70
11408526
Ann Intern Med. 1992 Aug 1;117(3):234-42
1616218
Clin Ther. 2005 Nov;27(11):1795-805
16368450
Clin Ther. 2001 Jan;23(1):108-23
11219471
Clin Ther. 2001 Jun;23(6):833-50
11440284
Congest Heart Fail. 2003 Nov-Dec;9(6):324-32
14688505
Am J Cardiol. 1987 Oct 1;60(10):801-6
3661393
Manag Care. 2000 Sep;9(9 Suppl):2-6
11729417
Expert Rev Cardiovasc Ther. 2003 May;1(1):43-50
15030296
Int J Clin Pract. 2003 May;57(4):273-9
12800457
Cardiovasc Diabetol. 2005 May 15;4:6
15892894
Curr Hypertens Rep. 2005 Aug;7(4):249-56
16061042
Circulation. 2004 May 4;109(17):2054-7
15117841
Am J Ther. 2002 Mar-Apr;9(2):111-7
11897925
J Manag Care Pharm. 2003 Sep-Oct;9(5):424-9
14613440
Clin Ther. 2004 Aug;26(8):1228-36
15476904
Blood Press. 2002;11(3):173-81
12126264
J Clin Pharmacol. 2000 Dec;40(12 Pt 1):1323-30
11185630